vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and AMREP CORP. (AXR). Click either name above to swap in a different company.

ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $14.6M, roughly 1.6× AMREP CORP.). On growth, AMREP CORP. posted the faster year-over-year revenue change (93.8% vs 36.4%). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs -13.6%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

AMREP Corporation is a real estate and media services company based in Princeton, New Jersey, in the United States. It was founded in 1961 as The American Realty and Petroleum Corporation.

ADCT vs AXR — Head-to-Head

Bigger by revenue
ADCT
ADCT
1.6× larger
ADCT
$23.1M
$14.6M
AXR
Growing faster (revenue YoY)
AXR
AXR
+57.4% gap
AXR
93.8%
36.4%
ADCT
Faster 2-yr revenue CAGR
ADCT
ADCT
Annualised
ADCT
13.7%
-13.6%
AXR

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
ADCT
ADCT
AXR
AXR
Revenue
$23.1M
$14.6M
Net Profit
$3.1M
Gross Margin
Operating Margin
-77.7%
20.6%
Net Margin
21.6%
Revenue YoY
36.4%
93.8%
Net Profit YoY
338.9%
EPS (diluted)
$0.04
$0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
AXR
AXR
Q1 26
$14.6M
Q4 25
$23.1M
$9.4M
Q3 25
$15.8M
$17.9M
Q2 25
$18.1M
$11.2M
Q1 25
$17.4M
$7.5M
Q4 24
$16.9M
$11.9M
Q3 24
$18.0M
$19.1M
Q2 24
$17.0M
$19.5M
Net Profit
ADCT
ADCT
AXR
AXR
Q1 26
$3.1M
Q4 25
$1.2M
Q3 25
$-41.0M
$4.7M
Q2 25
$-56.6M
$3.9M
Q1 25
$-38.6M
$717.0K
Q4 24
$4.0M
Q3 24
$-44.0M
$4.1M
Q2 24
$-36.5M
$4.1M
Operating Margin
ADCT
ADCT
AXR
AXR
Q1 26
20.6%
Q4 25
-77.7%
11.9%
Q3 25
-196.6%
34.4%
Q2 25
-244.1%
31.7%
Q1 25
-163.5%
5.7%
Q4 24
-191.8%
26.4%
Q3 24
-197.4%
26.1%
Q2 24
-170.5%
23.9%
Net Margin
ADCT
ADCT
AXR
AXR
Q1 26
21.6%
Q4 25
12.8%
Q3 25
-260.1%
26.3%
Q2 25
-313.2%
34.8%
Q1 25
-221.8%
9.5%
Q4 24
33.9%
Q3 24
-244.1%
21.3%
Q2 24
-214.6%
21.2%
EPS (diluted)
ADCT
ADCT
AXR
AXR
Q1 26
$0.58
Q4 25
$0.04
$0.22
Q3 25
$-0.30
$0.87
Q2 25
$-0.50
$0.73
Q1 25
$-0.36
$0.13
Q4 24
$-0.26
$0.75
Q3 24
$-0.42
$0.76
Q2 24
$-0.38
$0.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
AXR
AXR
Cash + ST InvestmentsLiquidity on hand
$261.3M
$50.0M
Total DebtLower is stronger
$21.0K
Stockholders' EquityBook value
$-185.8M
$139.4M
Total Assets
$323.1M
$143.9M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
AXR
AXR
Q1 26
$50.0M
Q4 25
$261.3M
$44.6M
Q3 25
$234.7M
$48.9M
Q2 25
$264.6M
$39.5M
Q1 25
$194.7M
$36.9M
Q4 24
$250.9M
$40.1M
Q3 24
$274.3M
$40.4M
Q2 24
$300.1M
$29.7M
Total Debt
ADCT
ADCT
AXR
AXR
Q1 26
$21.0K
Q4 25
$23.0K
Q3 25
$25.0K
Q2 25
$26.0K
Q1 25
$29.0K
Q4 24
$32.0K
Q3 24
$34.0K
Q2 24
$35.0K
Stockholders' Equity
ADCT
ADCT
AXR
AXR
Q1 26
$139.4M
Q4 25
$-185.8M
$136.0M
Q3 25
$-238.2M
$134.7M
Q2 25
$-199.2M
$130.0M
Q1 25
$-238.2M
$126.0M
Q4 24
$-202.6M
$125.1M
Q3 24
$-171.9M
$122.2M
Q2 24
$-131.7M
$118.0M
Total Assets
ADCT
ADCT
AXR
AXR
Q1 26
$143.9M
Q4 25
$323.1M
$140.1M
Q3 25
$289.8M
$140.7M
Q2 25
$321.6M
$133.8M
Q1 25
$272.5M
$128.9M
Q4 24
$322.0M
$129.1M
Q3 24
$349.1M
$127.0M
Q2 24
$371.8M
$122.8M
Debt / Equity
ADCT
ADCT
AXR
AXR
Q1 26
0.00×
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
AXR
AXR
Operating Cash FlowLast quarter
$-31.1M
$5.4M
Free Cash FlowOCF − Capex
$5.4M
FCF MarginFCF / Revenue
37.0%
Capex IntensityCapex / Revenue
0.0%
0.1%
Cash ConversionOCF / Net Profit
1.72×
TTM Free Cash FlowTrailing 4 quarters
$20.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
AXR
AXR
Q1 26
$5.4M
Q4 25
$-31.1M
$-4.3M
Q3 25
$-29.6M
$9.5M
Q2 25
$-24.1M
$10.2M
Q1 25
$-56.3M
$-3.2M
Q4 24
$-21.9M
$-182.0K
Q3 24
$-25.0M
$10.7M
Q2 24
$-32.8M
$10.7M
Free Cash Flow
ADCT
ADCT
AXR
AXR
Q1 26
$5.4M
Q4 25
$-4.3M
Q3 25
$9.5M
Q2 25
$9.7M
Q1 25
$-56.6M
$-3.3M
Q4 24
$-21.9M
$-268.0K
Q3 24
$-25.3M
$10.7M
Q2 24
$-32.9M
$10.3M
FCF Margin
ADCT
ADCT
AXR
AXR
Q1 26
37.0%
Q4 25
-45.9%
Q3 25
53.2%
Q2 25
86.4%
Q1 25
-325.2%
-43.4%
Q4 24
-129.8%
-2.3%
Q3 24
-140.2%
55.8%
Q2 24
-193.0%
52.5%
Capex Intensity
ADCT
ADCT
AXR
AXR
Q1 26
0.1%
Q4 25
0.0%
0.6%
Q3 25
0.0%
0.1%
Q2 25
0.0%
5.2%
Q1 25
1.5%
0.3%
Q4 24
0.5%
0.7%
Q3 24
1.2%
0.2%
Q2 24
0.2%
2.3%
Cash Conversion
ADCT
ADCT
AXR
AXR
Q1 26
1.72×
Q4 25
-3.54×
Q3 25
2.03×
Q2 25
2.63×
Q1 25
-4.51×
Q4 24
-0.05×
Q3 24
2.63×
Q2 24
2.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons